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Volume Minimums in
Interventional Cardiology*
THOMAS J. RYAN, MD, FACC
Boston, Massachusetts
Although it has been suggested for more than a decade that
individual operator experience has significant influence on the
outcome of percutaneous coronary angioplasty (PTCA) (1–4),
much as it does for coronary bypass graft surgery (CABG)
(5,6), there were few established data to support the guidelines
for credentialing interventional operators when they were first
proposed in 1988–1990 (4,7). By 1997, however, abundant data
have accrued to demonstrate a powerful inverse relationship
exists between major procedural complications and both insti-
tutional and individual operator annual case volumes (8–12).
Kimmel et al. were the first to use a detailed clinical database
(Society for Cardiac Angiography and Interventions Registry)
to make adjustments in case mix among 48 cardiac catheter-
ization laboratories, involving 19,594 patients undergoing a
first coronary balloon angioplasty, to assess the relationship
between institutional annual angioplasty volume and major
complications. They found a significant decrease in the rates of
in-hospital mortality, emergency bypass surgery, and peripro-
cedural MI with increasing catheterization laboratory volumes.
After risk adjusting using multivariable analysis these associa-
tions persisted. A statistically significant decrease in major
complications was observed in laboratories performing more
than 400 procedures per year (adjusted OR, 0.66; 95% CI,
0.46–0.96; p 5 0.03).
In the 1997 literature alone there are three major publica-
tions reporting on an experience with over 172,000 angioplasty
procedures that correlate outcome with individual physician
experience in very large databases enrolling tens of thousands
of patients carefully characterized to allow adjustment for
baseline and procedural risk (10–12). Hannan et al. reported
the overall in-hospital mortality rate for patients undergoing
PTCA in New York during 1991–94 was 0.9%, and the
same-stay CABG surgery rate was 3.43%. The risk adjusted
rate same-stay bypass surgery for patients treated by physicians
with caseloads in excess of 175 cases was 2.84%, while this rose
to 3.93% for patients treated by physicians with less than 75
cases per year. The same trend was noted for in-hospital
mortality with the risk-adjusted likelihood of death for patients
treated by operators with .175 cases per year being 0.8%,
while it was 1.03% for patients treated by operators with ,75
cases per year (10). Ellis et al. (11) examined 12,985 proce-
dures performed by 38 operators in five high-volume United
States centers. After adjusting for risk, they found that both the
outcome of death and a composite outcome of death, Q-wave
infarction, or emergency CABG was strongly related to the
number of cases each operator performed annually. Major
complications occurred in 9.3% of patients undergoing proce-
dures by operators who performed less than 70 cases annually,
compared with 2.9% when procedures were undertaken by
operators who performed .270 cases annually. This 69%
decrease in major complications was highly significant (p ,
0.001). Even when approaching low-risk cases, low-volume
operators experience more than twice as many complications
(5.9% vs. 1.7–2.4%, p , 0.001) as physicians with higher
annual case numbers. Similar findings are also reported by
Jollis et al. (12), who examined in-hospital bypass surgery and
death after angioplasty according to 1992 physician and hos-
pital Medicare procedure volume. This study involves 6,115
physicians who performed angioplasty on 97,478 Medicare
patients at 984 hospitals. The median number of procedures
performed per physician and per hospital were 13 and 98,
respectively. The authors concluded that more than 50% of
physicians and 20% of hospitals performing coronary angio-
plasty in 1992 probably failed to meet the minimum volume
guidelines that were initially published in 1988, and these
patients had worse outcomes. After adjusting for age, sex, race,
acute myocardial infarction, and comorbidity, low-volume phy-
sicians were associated with higher rates of same-stay bypass
surgery (p , 0.001) and low-volume hospitals were associated
with higher rates of same-stay bypass surgery and death (p ,
0.001). An improvement in outcome was seen up to threshold
values of 75 Medicare cases per physician and 200 Medicare
cases per hospital.
As compelling as these data are, the populations studied
underwent their interventional procedures in a time frame
prior to the widespread use of intracoronary stents. In a recent
Current Perspectives on the subject of stenting, Narins et al.
stated that “intracoronary stents have had a dramatic impact
on reduction of the incidence of acute complications after
failed balloon angioplasty and . . . the results of balloon angio-
plasty have also benefited greatly from the availability of
coronary stents for both bailout (for actual or threatened
abrupt closure) or back up (for suboptimal balloon results)
indications, potentially allowing for a strategy of more aggres-
sive balloon dilatation than could be safely performed in the
pre-stent era” (13). This has resulted in the practice of stent
implantation in more than one-half of all percutaneous inter-
ventions in the United States and Europe (14,15). In a recent
editorial, Teirstein claims that stents have “made coronary
angioplasty easier and more accessible to the less experienced
operator” (16). This has led to the view by many that the
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coronary stent is the great equalizer of physician expertise.
There are those who would refute the spate of recent articles
showing a clear relationship between operator and institutional
volume and procedural outcome for angioplasty by claiming
that with the introduction of these endovascular scaffolds
(stents) there is no longer a need to insist on procedural
volume minimums.
Appearing in this issue of the Journal, Kastrati and his
colleagues report their single-center experience in Munich
with 3,409 consecutive patients undergoing coronary stent
placement for the management of coronary artery disease (17).
Using a composite endpoint of cardiac death, myocardial
infarction, and aorto-coronary bypass surgery during the first
30 d after stent deployment, they show a convincing depen-
dency of favorable outcomes on individual operator experience
with stent procedures. They compared both the operators total
experience at the time of a given procedure as well as his/her
yearly volume experience. An adverse clinical outcome oc-
curred in 102 of 3,409 patients (2.99%). Operators with total
volumes above 483 procedures were associated with a signifi-
cantly lower risk-adjusted adverse outcome rate of 1.70 6
1.28%. While operators with yearly volumes of under 90
procedures were associated with a risk-adjusted adverse out-
come rate of 4.59 6 1.17%. This is significantly higher than the
overall rate of 2.99%.
Four variables emerged as independent risk factors for an
adverse outcome as identified by multivarite analysis and
included, in order of potency, complex lesions, unstable an-
gina, reduced left ventricular function, and operator volume.
These independent predictors were also entered into a classi-
fication and regression tree analysis (CART) to permit risk
stratification based on patient and lesion characteristics in
addition to operator experience measures. This analysis dem-
onstrated that, even for patietns with simple lesions, the
operator should have performed a minimum number of 100
procedures to ensure acceptable results. A yearly volume of
140 procedures was associated with an OR of 0.63 (0.44–0.89)
as compared with a volume of 70 procedures per year.
This group of investigators has a particularly extensive
experience with intracoronary stents and they are largely
responsible for the dramatic expansion of stent use around the
world. This is attributable to the impact of their landmark
study that was the first to show that the time-consuming effort
of vigorous anticoagulation with heparin, phenprocoumon,
and aspirin was associated with higher rates of an adverse
outcome than the simpler use of the combined antiplatelet
agents aspirin and ticlopidine (18). To their credit, in the
present study the investigators extended their period of obser-
vation out until 30 d after stent placement, which not only
provided additional endpoints for analysis to avoid the risk of
their investigation being underpowered, but such a strategy
may be particularly important for stent implantation where
thrombotic vessel occlusion is known to occur beyond the first
week of implantation (19,20). Also contributing to the high
event rate of this modest size study is the fact that 70% of the
target lesions were considered complex according to the mod-
ified American College of Cardiology/American Heart Asso-
ciation Scoring system (type B2 or C).
These data will certainly have to be replicated by other
investigators, using not only the hand-crimped, slotted tube
stents mounted on balloons of different sizes such as in this
study, but the more commonly used stents as well, involving
greater numbers of patients via the multi-center approach.
This study stands as an attractive model for subsequent
investigations not only because of the quality of its definition of
terms but also for its limited exclusions, rigorous execution,
and creative analyses. It is interesting to note the use of the
variable, procedural failure, as a secondary endpoint because of
its subjective nature. When analyzed, the 71 procedural fail-
ures represented 2.1% of all procedures but resulted in an
adverse outcome for 45% of the patients involved compared
with 2% for patients with successful procedures. Not unexpect-
edly, the most frequent reason for procedural failure was the
inability to reach the target lesion with stent, and multiple
logistic regression showed that complex lesions, small vessel
size, and low operator volume were the only independent risk
factors for this outcome.
Considering all the angst engendered by the ACC/AHA
recommendations that 75 interventional procedures per year
should be considered the minimum volume for maintenance of
competence among interventionalists, there is a lesson to be
learned from this paper from abroad and it is clearly stated in
the concluding paragraph: “This study demonstrated that
parallel to other patient and lesion characteristics, operator
experience exerts an independent influence on the outcome of
patients undergoing coronary stent placement. These results
suggest that the current guidelines of the American College of
Cardiology and the American Heart Association for achieving
and maintaining competency in PTCA, i.e., 125 procedures
performed during the training period and 75 procedures
performed annually, are also valid criteria for coronary stent
placement.”
References
1. Hartzler GO. Percutaneous transluminal coronary angioplasty: view of a
single relatively high frequency operator. Am J Cardiol 1986;57:869–72.
2. Roubin GS, Douglas JS, Jr., King SB III, et al. Percutaneous coronary
angioplasty: influence of operator experience on results. Am J Cardiol
1986;57:873–4.
3. The Society for Cardiac Angiography. Guidelines for credentialing and
facilities for performance of coronary angioplasty. Cathet Cardiovasc Diagn
1988;15:136–8.
4. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous
transluminal coronary angioplasty. A report of the American College of
Cardiology/American Heart Association Task Force on Assessment of
Diagnostic and Therapeutic Cardiovascular Procedures (Committee on
Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol
1988;12:529–45.
5. Luft HS, Bunker JP, Enthoven AC, et al. Should operations be regionalized?
The empirical relation between surgical volume and mortality. N Engl J Med
1979;301:1364–9.
6. Hannan EL, O’Donnell JF, Kilburn H, Jr., Bernard HR, Yazici A. Investi-
gation of the relationship between volume and mortality for surgical
procedures performed in New York State hospitals. J Am Med Assoc.
1989;262:503–10.
978 RYAN JACC Vol. 32, No. 4
EDITORIAL COMMENT October 1998:977–9
7. Ryan TJ, Klocke FJ, Reynolds WA, et al. Clinical competence in percuta-
neous transluminal coronary angioplasty. A statement for physicians from
the ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology. J Am
Coll Cardiol 1990;15:1469–74.
8. Kimmel SE, Berlin JA, Laskey WK, et al. The relationship between coronary
angioplasty procedure volume and major complications. J Am Med Assoc.
1995;274:1137–42.
9. Ryan TJ. The critical question of procedure volume minimums for coronary
angioplasty. J Am Med Assoc 1995;274:1169–70.
10. Hannan E, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome
relationships for hospital and operators in New York State. 1991–1994. J Am
Med Assoc. 1997;279:892–8.
11. Ellis SG, Weintraub W, Holmes DR, Jr., et al. Relation of operator volume and
experience to procedural outcome of percutaneous coronary revascularization
at hospitals with high interventional volumes. Circulation 1997;96:2479–84.
12. Jollis JG, Peterson ED, Nelson CL, et al. Relationship between physician
and hospital coronary angioplasty volume and outcome in elderly patients.
Circulation 1997;95:2485–91.
13. Narins CR, Holmes DR, Topol EJ. A call for provisional stenting: the
balloon is back! Circulation 1998;97:1298–305.
14. Meyer BJ, Meier B, Bonzel T, et al. Interventional cardiology in Europe
1993. Working group on coronary circulation of the European Society of
Cardiology. Eur Heart J 1996;17:1318–28.
15. Balcon R, Beyar R, Chierchia S, et al. Recommendations on stent manu-
facture, implantation and utilization. Study group of the working group on
coronary circulation. Eur Heart J 1997;18:1536–47.
16. Tierstein PS. Credentialing for coronary intervention: Practice makes per-
fect. Circulation 1997;95:2467–70.
17. Kastrati A, Neuman FJ, Scho¨mig A. Operator volume and outcome of
patients undergoing coronary stent placement. J Am Coll Cardiol 1998;32:
970–6.
18. Schomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of
antiplatelet and anticoagulation therapy after the placement of coronary
artery stents. N Engl J Med 1996;334:1084–9.
19. Lindsay J, Jr., Pinnow EE, Popma JJ, Picard AD. Obstacles to outcomes
analysis in percutaneous transluminal coronary revascularization. Am J
Cardiol 1995;76:168–72.
20. Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis:
evolving issues and current concepts. J Am Coll Cardiol 1996;27:494–503.
979JACC Vol. 32, No. 4 RYAN
October 1998:977–9 EDITORIAL COMMENT
